ELEUTHÉROCOQUE
Food supplement declared in France, declaration No 2020-3-702
ELEUTHÉROCOQUE (ORFITO) is a food supplement declared in France. Status: retrait du marché annoncé pour le 20 February 2029. None of the rules we check flags an issue with its declared composition; vitamin and mineral doses are not published by Compl'Alim and are therefore not checked.
- Brand
- ORFITO
- Food business operator placing the product on the market
- BioUltime
- Status
- Retrait du marché annoncé pour le 20 February 2029
- Form
- Comprimé
- Daily dose
- 3 comprimés
- Directions for use
- 2 à 3 comprimés par jour, à avaler avec un grand verre d’eau au cours des repas.
Declaration 168014, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.
Regulatory points
- Information
Retrait du marché annoncé pour le 20 February 2029, according to Compl'Alim.
Source: Compl'Alim, food supplement declarations (France).
Declared composition
Plants
| Plant | Part | Preparation | Per day |
|---|---|---|---|
| Eleutherococcus senticosus (Rupr. et Maxim.) Maxim | Racine | Poudre (de plantes séchées ou broyées) | 1,200 mg |
Vitamins and minerals
Compl'Alim does not publish vitamin and mineral doses. The references below help you read the product label: EFSAEuropean Food Safety Authority. safety limit for adults and maximum dose set in France per product (Order of 9 May 2006, not revised since November 2006).
| Declared form | Nutrient | EFSA limit, adults | Maximum dose in France |
|---|---|---|---|
| Carbonate de magnésium | Magnésium | 250 mg | 300 mg |
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.
Label warnings
se conformer aux conseils d’utilisation. Ne pas dépasser la dose journalière recommandée. Tenir hors de portée des jeunes enfants. À utiliser dans le cadre d’une alimentation diversifiée et d’un mode de vie sain. À conserver à l’abri de la lumière, dans un endroit frais et sec.
This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Other declarations with the same name
This name is used by more than 10 declarations from different companies, so it does not identify one product. See every declaration with this name.
Brand : ORFITO